Compugen (CGEN) PT Lowered to $14 at Oppenheimer
Tweet
Share
E-mailGet Alerts CGEN Hot Sheet
Price: $2.07 --0%
Rating Summary:
10 Buy, 0 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Rating Summary:
10 Buy, 0 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Join SI Premium – FREE
Oppenheimer analyst Mark Breidenbach lowered the price target on Compugen (NASDAQ: CGEN) to $14.00 (from $17.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Outdoor Holding (POWW) PT Raised to $2.75 at Roth/MKM, reiterates Top Pick
- Southwest (LUV) PT Raised to $61 at UBS Ahead of Q2 Print
- Ralliant Corp. (RAL) PT Raised to $85 at Morgan Stanley: 'organic pathway to sustained HSD into 2027'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
